METLIFE INC

For the period ended Dec 31, 2024. Filed Feb 21, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 21, 2025

MET$101.67+3.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(In millions, except share and per share data)

	2024	2023
Assets
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of $160 and $184, respectively); and amortized cost: $307,421 and $300,555, respectively	$281,043	$281,412
Equity securities, at estimated fair value	712	757
Contractholder-directed equity securities and fair value option securities, at estimated fair value	10,672	10,331
Mortgage loans (net of allowance for credit loss of $800 and $721, respectively)	89,012	92,506
Policy loans	8,545	8,788
Real estate and real estate joint ventures (includes $378 and $317, respectively, under the fair value option; $65 and $0, respectively, of real estate held-for-sale; $183 and $0, respectively, relating to variable interest entities)	13,342	13,332
Other limited partnership interests	14,378	14,764
Short-term investments, principally at estimated fair value	5,156	6,045
Other invested assets (net of allowance for credit loss of $0 and $23, respectively; includes $1,851 and $1,993, respectively, of leveraged and direct financing leases; $424 and $333, respectively, relating to variable interest entities)	18,504	18,202
Total investments	441,364	446,137
Cash and cash equivalents, principally at estimated fair value	20,068	20,639
Accrued investment income	3,489	3,589
Premiums, reinsurance and other receivables (includes $47 and $0, respectively, relating to variable interest entities)	29,761	28,971
Market risk benefits, at estimated fair value	372	286
Deferred policy acquisition costs and value of business acquired	19,627	20,151
Current income tax recoverable	295	190
Deferred income tax asset	2,994	2,612
Goodwill	8,901	9,236
Other assets	11,082	11,139
Separate account assets	139,504	144,634
Total assets	$677,457	$687,584
Liabilities and Equity
Liabilities
Future policy benefits	$193,646	$196,406
Policyholder account balances	221,445	219,269
Market risk benefits, at estimated fair value	2,581	3,179
Other policy-related balances	18,899	19,736
Policyholder dividends payable	385	386
Payables for collateral under securities loaned and other transactions	17,128	17,524
Short-term debt (includes $133 and $0, respectively, relating to variable interest entities)	465	119
Long-term debt	15,086	15,548
Collateral financing arrangement	476	637
Junior subordinated debt securities	3,164	3,161
Deferred income tax liability	132	927
Other liabilities	36,843	35,805
Separate account liabilities	139,504	144,634
Total liabilities	649,754	657,331
Contingencies, Commitments and Guarantees (Note 24)
Equity
MetLife, Inc.’s stockholders’ equity:
Preferred stock, par value $0.01 per share; $3,905 aggregate liquidation preference	—	—
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,194,168,628 and 1,191,823,651 shares issued, respectively; 689,211,065 and 730,821,111 shares outstanding, respectively	12	12
Additional paid-in capital	33,791	33,690
Retained earnings	42,626	40,146
Treasury stock, at cost; 504,957,563 and 461,002,540 shares, respectively	(27,798)	(24,591)
Accumulated other comprehensive income (loss)	(21,186)	(19,242)
Total MetLife, Inc.’s stockholders’ equity	27,445	30,015
Noncontrolling interests	258	238
Total equity	27,703	30,253
Total liabilities and equity	$677,457	$687,584

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.